Somaclonal variation in solanaceous medicinal plants

Research output: Chapter in Book/Report/Conference proceedingChapter or book articleScientificpeer-review

Abstract

A wide range of pharmaceutical secondary metabolites, derived from several higher plants, have been used to benefit mankind for many thousands of years. Many of these compounds have been known for years, and are still being used as the drugs of choice for specific therapy, e.g. Digitalis cardiac glycosides such as digoxin (Parr, 1989). Furthermore, new compounds are being isolated from the plant kingdom, and are actively screened. The chemical synthesis of most of the plant-derived compounds is possible; however, it is usually complicated, requires several steps in the biosynthetic pathway, and is thus uneconomical. Plant cell cultures offer an alternative approach to produce valuable plant compounds and they can also be used in plant breeding (Verpoorte et al., 1993). Plant tissue culture-derived variation among regenerated plants, or somaclonal variation, has been extensively studied, especially in crop plants such as sugarcane, tobacco, rice, maize and barley (Larkin and Scowcroft, 1981; Peschke and Phillips, 1992). However, surprisingly little information is available on the applications of somaclonal variation in medicinal plants and their cell cultures.
Original languageEnglish
Title of host publicationSomaclonal Variation and Induced Mutations in Crop Improvement
Place of PublicationDordrecht
PublisherSpringer
Pages233-251
ISBN (Electronic)978-94-015-9125-6
ISBN (Print)978-90-481-4956-8
DOIs
Publication statusPublished - 1998
MoE publication typeA3 Part of a book or another research book

Publication series

NameCurrent Plant Science and Biotechnology in Agriculture
PublisherSpringer
Volume32

Fingerprint

somaclonal variation
medicinal plants
cell culture
digoxin
cardiac glycosides
Digitalis
drugs
parr
plant breeding
secondary metabolites
sugarcane
tissue culture
plant tissues
biochemical pathways
tobacco
barley
rice
therapeutics
synthesis
corn

Cite this

Oksman-Caldentey, K-M. (1998). Somaclonal variation in solanaceous medicinal plants. In Somaclonal Variation and Induced Mutations in Crop Improvement (pp. 233-251). Dordrecht: Springer. Current Plant Science and Biotechnology in Agriculture, Vol.. 32 https://doi.org/10.1007/978-94-015-9125-6_13
Oksman-Caldentey, Kirsi-Marja. / Somaclonal variation in solanaceous medicinal plants. Somaclonal Variation and Induced Mutations in Crop Improvement. Dordrecht : Springer, 1998. pp. 233-251 (Current Plant Science and Biotechnology in Agriculture, Vol. 32).
@inbook{38a858979d604876a8f03d5ff55e7462,
title = "Somaclonal variation in solanaceous medicinal plants",
abstract = "A wide range of pharmaceutical secondary metabolites, derived from several higher plants, have been used to benefit mankind for many thousands of years. Many of these compounds have been known for years, and are still being used as the drugs of choice for specific therapy, e.g. Digitalis cardiac glycosides such as digoxin (Parr, 1989). Furthermore, new compounds are being isolated from the plant kingdom, and are actively screened. The chemical synthesis of most of the plant-derived compounds is possible; however, it is usually complicated, requires several steps in the biosynthetic pathway, and is thus uneconomical. Plant cell cultures offer an alternative approach to produce valuable plant compounds and they can also be used in plant breeding (Verpoorte et al., 1993). Plant tissue culture-derived variation among regenerated plants, or somaclonal variation, has been extensively studied, especially in crop plants such as sugarcane, tobacco, rice, maize and barley (Larkin and Scowcroft, 1981; Peschke and Phillips, 1992). However, surprisingly little information is available on the applications of somaclonal variation in medicinal plants and their cell cultures.",
author = "Kirsi-Marja Oksman-Caldentey",
year = "1998",
doi = "10.1007/978-94-015-9125-6_13",
language = "English",
isbn = "978-90-481-4956-8",
series = "Current Plant Science and Biotechnology in Agriculture",
publisher = "Springer",
pages = "233--251",
booktitle = "Somaclonal Variation and Induced Mutations in Crop Improvement",
address = "Germany",

}

Oksman-Caldentey, K-M 1998, Somaclonal variation in solanaceous medicinal plants. in Somaclonal Variation and Induced Mutations in Crop Improvement. Springer, Dordrecht, Current Plant Science and Biotechnology in Agriculture, vol. 32, pp. 233-251. https://doi.org/10.1007/978-94-015-9125-6_13

Somaclonal variation in solanaceous medicinal plants. / Oksman-Caldentey, Kirsi-Marja.

Somaclonal Variation and Induced Mutations in Crop Improvement. Dordrecht : Springer, 1998. p. 233-251 (Current Plant Science and Biotechnology in Agriculture, Vol. 32).

Research output: Chapter in Book/Report/Conference proceedingChapter or book articleScientificpeer-review

TY - CHAP

T1 - Somaclonal variation in solanaceous medicinal plants

AU - Oksman-Caldentey, Kirsi-Marja

PY - 1998

Y1 - 1998

N2 - A wide range of pharmaceutical secondary metabolites, derived from several higher plants, have been used to benefit mankind for many thousands of years. Many of these compounds have been known for years, and are still being used as the drugs of choice for specific therapy, e.g. Digitalis cardiac glycosides such as digoxin (Parr, 1989). Furthermore, new compounds are being isolated from the plant kingdom, and are actively screened. The chemical synthesis of most of the plant-derived compounds is possible; however, it is usually complicated, requires several steps in the biosynthetic pathway, and is thus uneconomical. Plant cell cultures offer an alternative approach to produce valuable plant compounds and they can also be used in plant breeding (Verpoorte et al., 1993). Plant tissue culture-derived variation among regenerated plants, or somaclonal variation, has been extensively studied, especially in crop plants such as sugarcane, tobacco, rice, maize and barley (Larkin and Scowcroft, 1981; Peschke and Phillips, 1992). However, surprisingly little information is available on the applications of somaclonal variation in medicinal plants and their cell cultures.

AB - A wide range of pharmaceutical secondary metabolites, derived from several higher plants, have been used to benefit mankind for many thousands of years. Many of these compounds have been known for years, and are still being used as the drugs of choice for specific therapy, e.g. Digitalis cardiac glycosides such as digoxin (Parr, 1989). Furthermore, new compounds are being isolated from the plant kingdom, and are actively screened. The chemical synthesis of most of the plant-derived compounds is possible; however, it is usually complicated, requires several steps in the biosynthetic pathway, and is thus uneconomical. Plant cell cultures offer an alternative approach to produce valuable plant compounds and they can also be used in plant breeding (Verpoorte et al., 1993). Plant tissue culture-derived variation among regenerated plants, or somaclonal variation, has been extensively studied, especially in crop plants such as sugarcane, tobacco, rice, maize and barley (Larkin and Scowcroft, 1981; Peschke and Phillips, 1992). However, surprisingly little information is available on the applications of somaclonal variation in medicinal plants and their cell cultures.

U2 - 10.1007/978-94-015-9125-6_13

DO - 10.1007/978-94-015-9125-6_13

M3 - Chapter or book article

SN - 978-90-481-4956-8

T3 - Current Plant Science and Biotechnology in Agriculture

SP - 233

EP - 251

BT - Somaclonal Variation and Induced Mutations in Crop Improvement

PB - Springer

CY - Dordrecht

ER -

Oksman-Caldentey K-M. Somaclonal variation in solanaceous medicinal plants. In Somaclonal Variation and Induced Mutations in Crop Improvement. Dordrecht: Springer. 1998. p. 233-251. (Current Plant Science and Biotechnology in Agriculture, Vol. 32). https://doi.org/10.1007/978-94-015-9125-6_13